REDOX PHARMACEUTICAL CORP — Form D

REDOX PHARMACEUTICAL CORP of GREENVALE, NY, a company, filed a Form D exempt-offering notice with the SEC on 2010-01-11. The offering totals $2.3M, of which $123K was reported sold. Industry: Biotechnology.

Offering

• Filed: 2010-01-11
• Form: D
• Accession: 0000899341-10-000001
• Industry: Biotechnology
• Exemptions: 06
• Total offering: $2.3M
• Amount sold: $123K
• Remaining: $2.2M
• Minimum investment: $200
• Investors: 44
• Date of first sale: 2009-10-18
• Security types: equity
• Revenue range: No Revenues
• SEC file number: 021-89934-1N

Issuer

• Name: REDOX PHARMACEUTICAL CORP
• CIK: 0000899341
• Entity type: Corporation
• Jurisdiction: NEW YORK
• Address: 100 FOREST DRIVE, GREENVALE, NY, 11548
• Phone: 516-484-2600 X280

Officers, directors & promoters (1)

More

• CIK 899341 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search